NCCN guidelines focus on treatment options for patients with multiple myeloma
Cancer · 01.09.2025 · 131 (17)
DOI: 10.1002/cncr.70014 ↗Kurz gefasst
Leitlinie in der Zeitschrift Cancer, online erschienen am 31.08.2025. Verfasst von Mary Beth Nierengarten. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, recommendations highlight important updates specific to systemic therapy options for those with newly diagnosed or previously treated multiple myeloma. In addition, a persistent PSA level following radical prostatectomy for prostate cancer is associated with a worse prognosis, and outcomes show a reduction in treatment failure associated with dose‐escalated, hypofractionated radiation therapy for localized prostate cancer.
Zitieren
APA
Nierengarten, M. B. (2025). NCCN guidelines focus on treatment options for patients with multiple myeloma. Cancer, 131(17). https://doi.org/10.1002/cncr.70014
Vancouver
Nierengarten MB. NCCN guidelines focus on treatment options for patients with multiple myeloma. Cancer. 2025;131(17). doi:10.1002/cncr.70014
BibTeX
@article{Nierengarten2025,
author = {Nierengarten, Mary Beth},
title = {NCCN guidelines focus on treatment options for patients with multiple myeloma},
journal = {Cancer},
year = {2025},
volume = {131},
number = {17},
doi = {10.1002/cncr.70014}
}
EUVIMED